An interaction between digoxin and acarbose.
Ben-Ami
H
H
Krivoy
N
N
Nagachandran
P
P
Roguin
A
A
Edoute
Y
Y
D020909:Acarbose; D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D002216:Captopril / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000188:drug therapy*; D004077:Digoxin / Q000097:blood / Q000627:therapeutic use*; D004347:Drug Interactions; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D006442:Glycated Hemoglobin / Q000378:metabolism; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D014312:Trisaccharides / Q000627:therapeutic use*
D020909:Acarbose; D000925:Anticoagulants; D000959:Antihypertensive Agents; D002216:Captopril; D004077:Digoxin; D005665:Furosemide; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin; D014312:Trisaccharides